Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
about
Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral LeishmaniasisDNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvantVisceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesMimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.Novel recombinant multiepitope proteins for the diagnosis of asymptomatic leishmania infantum-infected dogs.A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.Fleas and Flea-Associated Bartonella Species in Dogs and Cats from Peru.Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis.A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis.Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12.Total Leishmania antigens with Poly(I:C) induce Th1 protective response.Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis.A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.Vector-Borne Diseases in Stray Dogs in Peninsular Malaysia and Molecular Detection of Anaplasma and Ehrlichia spp. from Rhipicephalus sanguineus (Acari: Ixodidae) Ticks.High-Resolution Molecular Typing of Trypanosoma cruzi in 2 Large Outbreaks of Acute Chagas Disease in Colombia.Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection.
P2860
Q27318412-D24AC7C3-251B-466A-BA0F-CD4A2EBC90C0Q28542668-41E875E3-4F46-4CC0-857D-CE86D4EEAE10Q34076804-5B3A7E26-34DF-40B1-9B5E-538A77312767Q34344080-3F20B628-A29C-461A-B4DE-C6BBCFA44A72Q35047624-D399E4F7-F102-45FF-85C8-71034CD1D483Q35540086-D4BD426E-F470-4932-B576-03227B5138CBQ35687444-BADA620A-E973-49E5-9C3F-73E3B56569DAQ35771515-BF3311AC-02B2-4F06-A121-5243D13A6CE8Q36211636-7A9F0C1B-37CA-4511-962E-DD2D239142C7Q37434214-379F91EF-8437-486A-ACAA-5D61F0CB352EQ39156593-F9DCCA6D-4F9C-41B6-AFCE-1F87CC30C02BQ39220181-CFAEDA70-BFF9-4385-9E1A-164BDC3E07D6Q39220191-522C3F16-C9BB-4F03-BF18-3EB1B64FEDB3Q39793006-B2E88628-EE91-43A7-ABC9-97064CBFDB96Q40049613-56313903-73E5-4506-A9C0-AB16D603B2FFQ40171180-15DB6DD3-9F94-48E1-85FA-2B518987EC61Q40244179-3CA0421F-B4D9-4C14-90AE-2B08AED7661DQ40400238-D8FE65F7-06D4-480B-8F76-6406848B1D8DQ40580509-E5321853-0642-4379-AF8D-CF72171B5E61Q48560747-A8663374-447D-4C16-AA79-4DD1E156242A
P2860
Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@ast
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@en
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@nl
type
label
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@ast
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@en
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@nl
prefLabel
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@ast
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@en
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@nl
P2093
P2860
P1476
Antigenicity and protective ef ...... gainst visceral leishmaniasis.
@en
P2093
Adriana M C C Martins
Adriana M C Canavaci
Ana Paula Fernandes
Carlos A P Tavares
Daniela P Lage
Diogo G Valadares
Eduardo A F Coelho
Lourena E Costa
Manuel Soto
Mariana C Duarte
P2860
P356
10.1371/JOURNAL.PNTD.0002148
P407
P577
2013-03-28T00:00:00Z